Principal Investigator: Isaac Hall
Keywords: SARS-CoV-2 , COVID-19 , Vaccine , Antibody , Immunocompromised , Immunosuppression , Transplantation Department: Nephrology
IRB Number: 00139840 Co Investigator: Hannah Imlay
Specialty: Nephrology and Hypertension, Nephrology and Hypertension, Nephrology and Hypertension, Nephrology and Hypertension
Sub Specialties: Dialysis, Pancreas Transplant, Kidney Transplant, General Neurology
Recruitment Status: Not yet recruiting

Contact Information

Isaac Hall
isaac.hall@hsc.utah.edu
2035892257

Simple Summary

To determine whether immune responses and side effect profiles differ between immunocompromised and healthy individuals.

Inclusion Criteria

We will adopt broad inclusion criteria because the goal of this study is to see whether COVID-19 vaccines result in different immune responses and side effects in immunocompromised individuals compared with healthy controls. Hence, we will include any patient clinically eligible to receive COVID-19 vaccination at the University of Utah. We will not restrict entry of patients into our study based on any demographic (other than age less than 12 years) or clinical parameters.

Exclusion Criteria

Age <12 years.

Participant Reimbursement

None